Oral treatment with the all-d-peptide RD2 enhances cognition in aged beagle dogs – A model of sporadic Alzheimer’s disease

Disease-modifying therapies to treat Alzheimer's disease (AD) are of fundamental interest for aging humans, societies, and health care systems. Predictable disease progression in transgenic AD models favors preclinical studies employing a preventive study design with an early pre-symptomatic tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kutzsche, Janine, Schemmert, Sarah, Bujnicki, Tuyen, Zafiu, Christian, Halbgebauer, Steffen, Kraemer-Schulien, Victoria, Pils, Marlene, Blömeke, Lara, Post, Julia, Kulawik, Andreas, Jürgens, Dagmar, Rossberg, Wolfgang M., Hümpel, Michael, Bannach, Oliver, Otto, Markus, Araujo, Joseph A., Willuweit, Antje, Willbold, Dieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440458/
https://www.ncbi.nlm.nih.gov/pubmed/37609390
http://dx.doi.org/10.1016/j.heliyon.2023.e18443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440458/
https://www.ncbi.nlm.nih.gov/pubmed/37609390
http://dx.doi.org/10.1016/j.heliyon.2023.e18443

Ejemplares similares